Aleksandar T.
- Country
- Bulgaria
- Department
- Internal Diseases, Gastroenterology
Research Overview
Data & Insights
Has run more than one trial at 0 of 11 partner sites.
Specializations
Liver Disease Management
This investigator specializes in the treatment of non-alcoholic steatohepatitis (NASH), with particular focus on advanced liver fibrosis stages. Their research encompasses innovative therapeutic approaches for patients with non-cirrhotic NASH and various stages of liver fibrosis.
- NASH Resolution
- Liver Fibrosis Treatment
- Non-cirrhotic Liver Disease
Their work involves evaluating novel therapeutic agents for liver disease management and fibrosis improvement.
Viral Hepatitis Treatment
The investigator demonstrates significant expertise in treating chronic Hepatitis B (CHB), focusing on combination therapeutic approaches. Their work includes evaluation of advanced treatment modalities including antisense oligonucleotides and targeted immunotherapy.
- Nucleos(t)ide Analogue Therapy
- Immunological Responses
- Sequential Treatment Protocols
Their research encompasses innovative sequential treatment strategies for chronic hepatitis management.
Therapeutic Innovation
The investigator's work extends to developing functional cure approaches for chronic viral infections, with particular emphasis on hepatitis B treatment optimization. Their research includes evaluation of novel therapeutic agents with specific loading dose protocols.
- Treatment Optimization
- Viral Load Management
- Long-term Disease Control
Their focus includes developing treatment protocols for achieving sustained virological response in chronic hepatitis patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.